The potential of artemether for the control of schistosomiasis (Q34455017)

2 August 2017

1 reference

title

The potential of artemether for the control of schistosomiasis (English)

1 reference

2 August 2017

0 references

1 reference

5

Tanner M

1 reference

2 August 2017

3

N'Goran EK

1 reference

2 August 2017

Utzinger J

1

1 reference

PubMed ID

11730781

2 August 2017

Xiao S

series ordinal

2

1 reference

PubMed ID

11730781

2 August 2017

Bergquist R

series ordinal

4

1 reference

2 August 2017

1 December 2001

1 reference

International Journal for Parasitology

2 August 2017

1 reference

2 August 2017

31

1 reference

2 August 2017

14

1 reference

2 August 2017

1549-1562

1 reference

Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Activity of the artemether in experimental schistosomiasis mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Fatal neurotoxicity of arteether and artemether

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Neurotoxicity in animals due to arteether and artemether.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

The global status of schistosomiasis and its control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Chemotherapy of schistosomiasis: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel: is there real resistance and are there alternatives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Antischistosomal drugs: past, present ... and future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

IN VITRO CULTIVATION OF SCHISTOSOMA MANSONI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Detection of schistosome antigen in mummies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Current status of artemisinin and its derivatives as antimalarial drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel and the control of schistosomiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

The role of molluscicides in schistosomiasis control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Drug resistance in human helminths: current situation and lessons from livestock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Post-transmission schistosomiasis: a new agenda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel, a new broad-spectrum antischistosomal agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

From katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Qinghaosu (artemisinin): an antimalarial drug from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel--its use, cost and possible development of resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Detection of praziquantel resistance in schistosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

The Brazilian program for schistosomiasis control, 1975-1979.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Artemisinin derivatives for treating severe malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Palaeoepidemiology of Schistosoma infection in mummies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Radical mechanism of action of the artemisinin-type compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Artemisinin drugs: novel antimalarial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

An international initiative on praziquantel use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Schistosoma mansoni: chemotherapy of infections of different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Culture ofSchistosoma haematobium in vivoandin vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Antimalarial drug resistance and combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Averting a malaria disaster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

The prophylactic effects of artemether against Schistosoma japonicum infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Preventive effect of artemether in experimental animals infected with Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Tegumental changes in adult Schistosoma mansoni harbored in mice treated with artemether

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Effect of artemether against Schistosoma haematobium in experimentally infected hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Artemether administered together with haemin damages schistosomes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

Histopathological changes in juvenile Schistosoma haematobium harboured in hamsters treated with artemether

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

The 1992-1999 World Bank Schistosomiasis Research Initiative in China: outcome and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2801%2900297-1

10.1016/S0020-7519(01)00297-1

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11730781